FDA Application
-
NDC Search Results on Active Ingredient: codeine
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
CODEINE PHOSPHATE; ACETAMINOPHEN | 71335-0545-3 | Bryant Ranch Prepack | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 52959-003-24 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 71610-111-45 | Aphena Pharma Solutions - Tennessee, LLC | ANDA040419 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68071-3100-8 | NuCare Pharmaceuticals, Inc. | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 49999-026-60 | Quality Care Products LLC | ANDA040419 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 71335-0256-6 | Bryant Ranch Prepack | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 50090-3011-8 | A-S Medication Solutions | ANDA040419 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 49999-060-50 | Quality Care Products, LLC | ANDA040419 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 13107-060-99 | Aurolife Pharma, LLC | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 71205-001-60 | Proficient Rx LP | ANDA088628 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 71205-001-30 | Proficient Rx LP | ANDA088628 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 68387-250-15 | Keltman Pharmaceuticals, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN; CAFFEINE; BUTALBITAL | 0591-3220-01 | Actavis Pharma, Inc. | NDA020232 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
CODEINE PHOSPHATE; BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE | 23359-023-16 | Centurion Labs, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; BUTALBITAL; ACETAMINOPHEN; CAFFEINE | 52544-082-01 | Actavis Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; BUTALBITAL; ACETAMINOPHEN; CAFFEINE | 0591-2641-01 | Actavis Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; BUTALBITAL; ASPIRIN; CAFFEINE | 0722-6094-05 | Nexgen Pharma, Inc. | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; BUTALBITAL; ASPIRIN; CAFFEINE | 0722-6094-01 | Nexgen Pharma, Inc. | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; CAFFEINE; ASPIRIN; BUTALBITAL | 79739-6094-1 | LGM PHARMA SOLUTIONS, LLC | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 71269-040-10 | Mainpointe Pharmaceuticals | NDA206323 | HUMAN PRESCRIPTION DRUG | NDA |
CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 43378-105-08 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 60575-212-16 | Respa Pharmaceuticals, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 71269-040-30 | Mainpointe Pharmaceuticals | NDA206323 | HUMAN PRESCRIPTION DRUG | NDA |
CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 43378-104-08 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
CODEINE PHOSPHATE; GUAIFENESIN | 0682-0475-16 | Marnel Pharmaceuticals, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
CODEINE PHOSPHATE; GUAIFENESIN | 0121-1550-10 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
CODEINE PHOSPHATE; GUAIFENESIN | 54932-208-86 | BioRamo, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
CODEINE PHOSPHATE; GUAIFENESIN | 0121-1550-40 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
CODEINE PHOSPHATE; GUAIFENESIN | 50090-1428-0 | A-S Medication Solutions | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
CODEINE PHOSPHATE; GUAIFENESIN | 53002-3191-1 | RPK Pharmaceuticals, Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-420 | 421-450 | 451-480 | 481-510 | 511-540 | 541-570 | 571-600 |
601-630 | 631-660 | 661-690 | 691-720 | 721-750 | 751-764 |
-